TGFB1 and diabetic kidney disease: In diabetic nephropathy models, FL2 decreases collagen accumulation induced by advanced glycation end products (AGEs), regulates α-SMA expression, and suppresses profibrotic pathways such as TGF-β1 and SMAD2/3, thus blocking signals that promote renal fibrosis [31].